S772 Risankizumab Therapy Induces Improvements in Endoscopic Endpoints in Patients With Moderate-To-Severe Crohn's Disease: Results From the Phase 3 ADVANCE and MOTIVATE Studies. (October 2021) - Bossuyt, Peter; Ferrante, Marc; Baert, Filip; Danese, Silvio; Feagan, Brian; Loftus, Edward V.; Panés, Julian; Peyrin-Biroulet, Laurent; Ran, Zhihua; Armuzzi, Alessandro; D'Haens, Geert; Song, Alexandra; et al.